Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma

被引：0
|
作者：
Pascal Chastagner
Bénédicte Devictor
Birgit Geoerger
Isabelle Aerts
Pierre Leblond
Didier Frappaz
Jean-Claude Gentet
Serge Bracard
Nicolas André
机构：
[1] Children University Hospital,Paediatric Oncology Department
[2] University Hospital la Timone AP-HM,Pharmacokinetic and Toxicology Laboratory
[3] Gustave Roussy,Paediatric and Adolescent Oncology Department
[4] Curie Institute,Paediatric Adolescent and Young Adults Oncology Department
[5] Oscar Lambret,Paediatric Oncology Department
[6] Institut d’hémato-oncologie pédiatrique,Paediatric Oncology Department
[7] University Children Hospital la Timone,Neuroradiology Department
[8] University Hospital,INSERM UMR 911, Centre de Recherche en Oncologie biologique et en Oncopharmacologie
[9] Aix-Marseille University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Liposomal doxorubicin; Myocet; Pharmacokinetic; Children; Phase I trial; High-grade glioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 432
页数：7
相关论文
共 50 条
  • [1] Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma
    Chastagner, Pascal
    Devictor, Benedicte
    Geoerger, Birgit
    Aerts, Isabelle
    Leblond, Pierre
    Frappaz, Didier
    Gentet, Jean-Claude
    Bracard, Serge
    Andre, Nicolas
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 425 - 432
  • [2] PHASE I STUDY OF NON-PEGYLATED LIPOSOMAL DOXORUBICIN IN CHILDREN WITH RECURRENT/REFRACTORY HIGH GRADE GLIOMA
    Chastagner, P.
    Devictor, B.
    Geoerger, B.
    Aerts, I.
    Leblond, P.
    Frappaz, D.
    Gentet, J. C.
    Pall-Kondolff, S.
    Andre, N.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S159 - S159
  • [3] Preclinical Studies of Pegylated- and Non-Pegylated Liposomal Forms of Doxorubicin as Radiosensitizer on Orthotopic High-Grade Glioma Xenografts
    Chastagner, P.
    Sudour, H.
    Mriouah, J.
    Barberi-Heyob, M.
    Bernier-Chastagner, V.
    Pinel, S.
    [J]. PHARMACEUTICAL RESEARCH, 2015, 32 (01) : 158 - 166
  • [4] Preclinical Studies of Pegylated- and Non-Pegylated Liposomal Forms of Doxorubicin as Radiosensitizer on Orthotopic High-Grade Glioma Xenografts
    P. Chastagner
    H. Sudour
    J. Mriouah
    M. Barberi-Heyob
    V. Bernier-Chastagner
    S. Pinel
    [J]. Pharmaceutical Research, 2015, 32 : 158 - 166
  • [5] Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma
    Hau, P
    Fabel, K
    Baumgart, U
    Rümmele, P
    Grauer, O
    Bock, A
    Dietmaier, C
    Dietmaier, W
    Dietrich, J
    Dudel, C
    Hübner, F
    Jauch, T
    Drechsel, E
    Kleiter, I
    Wismeth, G
    Zellner, A
    Brawanski, A
    Steinbrecher, A
    Marienhagen, J
    Bogdahn, U
    [J]. CANCER, 2004, 100 (06) : 1199 - 1207
  • [6] Comparison of doxorubicin and its non-pegylated liposomal form as radiosensitizer in high grade glioma xenografts
    Chastagner, PB
    Labussière, M
    Pinel, S
    Bernier, V
    Fouyssac, F
    Plénat, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 124S - 124S
  • [7] COMPARISON OF INTRATUMORAL BIODISTRIBUTION OF A PEGYLATED AND A NON-PEGYLATED FORM OF LIPOSOMAL DOXORUBICIN IN ORTHOTOPIC HIGH GRADE GLIOMA XENOGRAFTS
    Chastagner, P.
    Sudour, H.
    Pinel, S.
    Barberi-Heyob, M.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II50 - II50
  • [8] Phase I/II study with pegylated liposomal doxorubicin in combination with oral topotecan in children with progressive high-grade glioma: An interim analysis
    Wagner, S.
    Fels, C.
    Hau, P.
    Janssen, G.
    Classen, C. F.
    Jorch, N.
    Peters, O.
    Bogdahn, U.
    Wolff, J. E. A.
    [J]. NEURO-ONCOLOGY, 2007, 9 (02) : 204 - 204
  • [9] Pegylated liposomal doxorubicin in recurrent high-grade glioma: Comparison of clinical trial results and compassionate use
    Glas, M.
    Koch, H.
    Hirschmann, B.
    Jauch, T.
    Steinbrecher, A.
    Bogdahn, U.
    Hau, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Pegylated liposomal doxorubicin in recurrent high-grade glioma: Comparison of clinical trial results and compassionate use
    Glas, M.
    Koch, H.
    Hirschmann, B.
    Jauch, T.
    Steinbrecher, A.
    Bogdahn, U.
    Hau, P.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 353 - 354
12345